Published in J Alzheimers Dis on January 01, 2010
A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease Neuroimaging Initiative cohort. Neuroimage (2012) 1.31
The neuropathology of chronic traumatic encephalopathy. Brain Pathol (2015) 1.24
Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging (2010) 1.01
The very same thing: Extending the object token concept to incorporate causal constraints on individual identity. Adv Cogn Psychol (2012) 0.97
Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes. J Neuropathol Exp Neurol (2012) 0.96
Nutrition and prevention of Alzheimer's dementia. Front Aging Neurosci (2014) 0.92
"End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction? J Alzheimers Dis (2011) 0.90
Behavioral symptoms related to cognitive impairment. Neuropsychiatr Dis Treat (2013) 0.89
Voxel-based morphometry findings in Alzheimer's disease: neuropsychiatric symptoms and disability correlations - preliminary results. Clinics (Sao Paulo) (2011) 0.88
DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease. Sci Rep (2014) 0.87
Proteomics of protein post-translational modifications implicated in neurodegeneration. Transl Neurodegener (2014) 0.86
Nutrition and the risk of Alzheimer's disease. Biomed Res Int (2013) 0.82
Intellectual Disability, Mild Cognitive Impairment, and Risk for Dementia. J Policy Pract Intellect Disabil (2013) 0.80
Nanopharmacology in translational hematology and oncology. Int J Nanomedicine (2014) 0.80
Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriers. Cortex (2014) 0.79
Fitting the epidemiology and neuropathology of the early stages of Alzheimer's disease to prevent dementia. Alzheimers Res Ther (2015) 0.78
Patient Satisfaction and Prognosis for Functional Improvement and Deterioration, Institutionalization, and Death Among Medicare Beneficiaries Over 2 Years. Arch Phys Med Rehabil (2016) 0.78
Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment. Curr Psychiatry Rep (2012) 0.77
Attention-deficit/hyperactivity disorder in childhood is associated with cognitive test profiles in the geriatric population but not with mild cognitive impairment or Alzheimer's disease. J Aging Res (2011) 0.76
Brain Transcriptome Sequencing of a Natural Model of Alzheimer's Disease. Front Aging Neurosci (2017) 0.75
Visual re-identification of individual objects: a core problem for organisms and AI. Cogn Process (2015) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72
Mild cognitive impairment: clinical characterization and outcome. Arch Neurol (1999) 33.06
Mild cognitive impairment as a diagnostic entity. J Intern Med (2004) 26.95
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology (1994) 21.65
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
A new rating scale for Alzheimer's disease. Am J Psychiatry (1984) 15.16
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10
Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med (2005) 12.04
The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry (1982) 10.83
What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc (2002) 9.81
Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) 9.27
Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology (2006) 8.97
Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.68
Age, neuropathology, and dementia. N Engl J Med (2009) 6.36
Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol (2006) 6.20
The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology (2008) 5.94
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA (2002) 5.77
Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17
The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord (2007) 5.01
Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol (2003) 4.82
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol (2006) 4.56
Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology (1992) 4.52
Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol (2007) 4.47
Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet (1997) 4.39
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol (2008) 4.14
Focal cortical presentations of Alzheimer's disease. Brain (2007) 4.07
Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol (2008) 3.99
Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology (2004) 3.94
Classification criteria for mild cognitive impairment: a population-based validation study. Neurology (2001) 3.92
Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage (2008) 3.74
Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand (2008) 3.65
Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc (2001) 3.62
Preclinical prediction of Alzheimer's disease using SPECT. Neurology (1998) 3.60
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology (2002) 3.57
"Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology (2000) 3.57
The evolution and pathology of frontotemporal dementia. Brain (2005) 3.46
Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc (2004) 3.43
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology (2004) 3.41
Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci (2001) 3.35
Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology (2006) 3.22
Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol (1998) 3.20
Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol (1999) 3.20
Cerebral white matter lesions and the risk of dementia. Arch Neurol (2004) 3.17
Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain (2000) 3.14
Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging (1992) 3.05
Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology (2003) 2.97
Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol (1998) 2.92
Mild cognitive impairment in the elderly: predictors of dementia. Neurology (1991) 2.83
Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol (2002) 2.68
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol (2007) 2.65
Predictors of driving safety in early Alzheimer disease. Neurology (2009) 2.61
Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsychologia (2008) 2.58
Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology (2005) 2.45
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44
Practice parameter: risk of driving and Alzheimer's disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology (2000) 2.43
Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology (1996) 2.31
Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr (1994) 2.24
Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology (2004) 2.20
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology (2001) 2.15
Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol (2006) 2.13
Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann N Y Acad Sci (2007) 2.11
Dementia and race: are there differences between African Americans and Caucasians? J Am Geriatr Soc (2001) 2.05
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology (2004) 2.00
Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies. Hippocampus (2009) 1.95
Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol (2008) 1.93
Worldwide variation in the doubling time of Alzheimer's disease incidence rates. Alzheimers Dement (2008) 1.89
Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia (2000) 1.87
Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria. Alzheimer Dis Assoc Disord (1993) 1.80
ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord (2006) 1.80
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology (2006) 1.68
Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology (1994) 1.67
Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study. Arch Neurol (1996) 1.61
Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord (2007) 1.61
Primary progressive aphasia: diagnosis, varieties, evolution. J Int Neuropsychol Soc (2003) 1.56
Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol (2008) 1.53
Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat (2003) 1.50
Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol Aging (1996) 1.49
Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Neurobiol Aging (2008) 1.49
Visual dysfunction, neurodegenerative diseases, and aging. Neurol Clin (2003) 1.45
Preclinical Alzheimer's disease: diagnosis and prediction of progression. Lancet Neurol (2005) 1.45
Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease. J Neuropathol Exp Neurol (1998) 1.42
The prevalence of dementia in the People's Republic of China: a systematic analysis of 1980-2004 studies. Age Ageing (2007) 1.40
Corticobasal syndrome associated with the A9D Progranulin mutation. J Neuropathol Exp Neurol (2007) 1.39
Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly. Neurobiol Aging (2001) 1.27
Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. Arch Neurol (2005) 1.22
Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiol Aging (2008) 1.20
Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias. J Neuropathol Exp Neurol (2005) 1.18
Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry (2000) 1.16
The functional neuroanatomy of geriatric depression. Int J Geriatr Psychiatry (2009) 1.16
Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment. Neurosci Lett (2008) 1.15
Clinical features of frontal lobe dementia in comparison to Alzheimer's disease. J Neural Transm Suppl (1996) 1.14
Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment. CNS Drugs (2004) 1.13
Current concepts in Alzheimer's disease: a multidisciplinary review. Am J Alzheimers Dis Other Demen (2009) 1.12
Dementia of the Alzheimer type. Epidemiol Rev (2008) 1.10